BI
Biocure Technology Inc.
BICTF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $527.0K
P/E Ratio -
Div. Yield -
ROE 10.41%
Bulios Fair Price
$0.02
100.0% upside
Current Price
$0.01
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BICTF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.33x
PEG N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 5.11%
ROIC 5.56%
Asset turnover 0.00x
Debt
46 /100
Moderate Int. coverage -8.56x
Debt/Equity 0.04x
Current ratio 0.10x
Stability
1 /100
Unstable Profitable years 0
Beta 3.78x
EPS volatility 241.25%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BICTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Yee Sing Cheng
Employees
3
Headquarters
Vancouver